EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer—2020 update. Part 1: screening, diagnosis, and local treatment with curative intent
N Mottet, RCN van den Bergh, E Briers… - European urology, 2021 - Elsevier
Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …
Preoperative exercise interventions to optimize continence outcomes following radical prostatectomy
SF Mungovan, SV Carlsson, GC Gass… - Nature Reviews …, 2021 - nature.com
Urinary incontinence is a common and predictable consequence among men with localized
prostate cancer who have undergone radical prostatectomy. Despite advances in the …
prostate cancer who have undergone radical prostatectomy. Despite advances in the …
Magnetic resonance imaging–guided vs computed tomography–guided stereotactic body radiotherapy for prostate cancer: the MIRAGE randomized clinical trial
Importance Magnetic resonance imaging (MRI) guidance offers multiple theoretical
advantages in the context of stereotactic body radiotherapy (SBRT) for prostate cancer …
advantages in the context of stereotactic body radiotherapy (SBRT) for prostate cancer …
Patient-reported outcomes 12 years after localized prostate cancer treatment
JL Donovan, FC Hamdy, JA Lane, GJ Young… - NEJM …, 2023 - evidence.nejm.org
Background Long-term patient-reported outcomes are needed to inform treatment decisions
for localized prostate cancer. Methods Patient-reported outcomes of 1643 randomly …
for localized prostate cancer. Methods Patient-reported outcomes of 1643 randomly …
Association of treatment modality, functional outcomes, and baseline characteristics with treatment-related regret among men with localized prostate cancer
Importance Treatment-related regret is an integrative, patient-centered measure that
accounts for morbidity, oncologic outcomes, and anxiety associated with prostate cancer …
accounts for morbidity, oncologic outcomes, and anxiety associated with prostate cancer …
MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study
Background Men with grade group 2 or 3 prostate cancer are often considered ineligible for
active surveillance; some patients with grade group 2 prostate cancer who are managed …
active surveillance; some patients with grade group 2 prostate cancer who are managed …
Functional outcomes after localized prostate cancer treatment
Importance Adverse outcomes associated with treatments for localized prostate cancer
remain unclear. Objective To compare rates of adverse functional outcomes between …
remain unclear. Objective To compare rates of adverse functional outcomes between …
Screening for prostate cancer
SV Carlsson, AJ Vickers - Medical Clinics, 2020 - medical.theclinics.com
Prostate cancer is a major public health problem across the globe. With 1.3 million new
cases and 359,000 deaths in 2018, prostate cancer is the second most common cancer and …
cases and 359,000 deaths in 2018, prostate cancer is the second most common cancer and …
Retzius-sparing robot-assisted radical prostatectomy leads to durable improvement in urinary function and quality of life versus standard robot-assisted radical …
J Egan, S Marhamati, FLF Carvalho, M Davis, J O'Neill… - European urology, 2021 - Elsevier
Background Retzius-sparing robot-assisted radical prostatectomy (RS-RARP) has been
shown to improve continence. However, questions remain regarding feasibility and …
shown to improve continence. However, questions remain regarding feasibility and …
Fifteen year quality of life outcomes in men with localised prostate cancer: population based Australian prospective study
Objective To assess treatment related changes in quality of life up to 15 years after
diagnosis of localised prostate cancer. Design Population based, prospective cohort study …
diagnosis of localised prostate cancer. Design Population based, prospective cohort study …